The Activities of 1'-acetoxychavicol Acetate on SW620 Colorectal Cancer Cells Line
DOI:
https://doi.org/10.59796/jcst.V15N4.2025.132Keywords:
colorectal cancer, 1'-acetoxychavicol acetate, anti-cancer, Kirsten rat sarcoma viral oncogene homolog, KRASAbstract
Cancer is a significant cause of mortality worldwide, including in Thailand. However, chemotherapy has serious side effects. Ongoing research on the compound 1'-acetoxychavicol acetate (ACA) has revealed various medicinal properties, including anticancer and anti-inflammatory activities. Although ACA has been found to affect cancer cell lines through different mechanisms, few reports have focused on its effectiveness against colorectal cancer cell lines. This research aims to determine the anticancer activities of ACA on the SW620 cell line. Anticancer activities, including anti-proliferation, anti-migration, and anti-invasion, were evaluated using methylthiazolyldiphenyl-tetrazolium bromide (MTT), colony formation, scratch assays, invasion assays, and qRT-PCR. The results showed that ACA exhibited cytotoxic effects (IC50 values) and anti-proliferative activity in a dose-dependent manner. ACA also demonstrated anti-migration and anti-invasion activities in a dose-dependent manner. Additionally, the qRT-PCR results showed that ACA significantly decreased Kirsten rat sarcoma viral oncogene homolog (KRAS) gene expressions compared to the control group. ACA exhibits anti-proliferative, anti-migratory, and anti-invasive activities in SW620 cells. These findings suggest the potential of ACA as a therapeutic agent and may provide insights that significantly advance our understanding of cancer biology and treatment.
References
Aiello, P., Sharghi, M., Mansourkhani, S. M., Ardekan, A. P., Jouybari, L., Daraei, N., ... & Kooti, W. (2019). Medicinal plants in the prevention and treatment of colon cancer. Oxidative Medicine and Cellular Longevity, 2019, Article 2075614. https://doi.org/10.1155/2019/2075614
Baradwaj, R. G., Rao, M. V., & Senthil Kumar, T. (2017). Novel purification of 1′S-1′-acetoxychavicol acetate from Alpinia galanga and its cytotoxic plus antiproliferative activity in colorectal adenocarcinoma cell line SW480. Biomedicine & Pharmacotherapy, 91, 485-493. https://doi.org/10.1016/j.biopha.2017.04.114
Bertotti, A., & Sassi, F. (2015). Molecular pathways: Sensitivity and resistance to anti-EGFR antibodies. Clinical Cancer Research, 21(15), 3377–3383. https://doi.org/10.1158/1078-0432.CCR-14-0848
Danaei, G., Vander Hoorn, S., Lopez, A. D., Murray, C. J., Ezzati, M., & Comparative Risk Assessment collaborating group (Cancers). (2005). Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors. The Lancet, 366(9499), 1784–1793. https://doi.org/10.1016/S0140-6736(05)67725-2
Jongrungraungchok, S., Madaka, F., Wunnakup, T., Sudsai, T., Pongphaew, C., Songsak, T., & Pradubyat, N. (2023). In vitro antioxidant, anti-inflammatory, and anticancer activities of a mixture of Thai medicinal plants. BMC Complementary Medicine and Therapies, 23, Article 43. https://doi.org/10.1186/s12906-023-03862-8
Horton, R. (2013). Non-communicable diseases: 2015 to 2025. The Lancet, 381(9866), 509–510. https://doi.org/10.1016/S0140-6736(13)60100-2
Iacopetta, B. (2003). TP53 mutation in colorectal cancer. Human Mutation, 21(3), 271–276. https://doi.org/10.1002/humu.10175
In, L. L., Arshad, N. M., Ibrahim, H., Azmi, M. N., Awang, K., & Nagoor, N. H. (2012). 1′-Acetoxychavicol acetate inhibits growth of human oral carcinoma xenograft in mice and potentiates cisplatin effect via proinflammatory microenvironment alterations. BMC Complementary and Alternative Medicine, 12, Article 179. https://doi.org/10.1186/1472-6882-12-179
Ketkomol, P., Songsak, T., Jongrungruangchok, S., Madaka, F., & Pradubyat, N. (2024). The effect of 1′-acetoxychavicol acetate on A549 human non-small cell lung cancer. Journal of Current Science and Technology, 14(2), Article 43. https://doi.org/10.59796/jcst.V14N2.2024.43
Kojima-Yuasa, A., & Matsui-Yuasa, I. (2020). Pharmacological effects of 1′-acetoxychavicol acetate, a major constituent in the rhizomes of Alpinia galanga and Alpinia conchigera. Journal of Medicinal Food, 23(5), 465–475. https://doi.org/10.1089/jmf.2019.4490
Lamouille, S., Xu, J., & Derynck, R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology, 15(3), 178–196. https://doi.org/10.1038/nrm3758
Mitry, E., Guiu, B., Cosconea, S., Jooste, V., Faivre, J., & Bouvier, A. M. (2010). Epidemiology, management and prognosis of colorectal cancer with lung metastases: A 30-year population-based study. Gut, 59(10), 1383–1388. https://doi.org/10.1136/gut.2010.211557
Nelson, V., Sahoo, N., Sahu, M., Pullaiah, C., & Muralikrishna, K. (2020). In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116. BMC Complementary Medicine and Therapies, 20(1), Article 355. https://doi.org/10.1186/s12906-020-03118-9
Phuah, N. H., In, L. L., Azmi, M. N., Ibrahim, H., Awang, K., & Nagoor, N. H. (2013). Alterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1′S-1′-acetoxychavicol acetate and cisplatin. Reproductive Sciences, 20(5), 567–578. https://doi.org/10.1177/1933719112459220
Pradubyat, N., Giannoudis, A., Elmetwali, T., Mahalapbutr, P., Palmieri, C., Mitrpant, C., & Ketchart, W. (2022). 1′-Acetoxychavicol acetate from Alpinia galanga represses proliferation and invasion, and induces apoptosis via HER2-signaling in endocrine-resistant breast cancer cells. Planta Medica, 88(2), 163–178. https://doi.org/10.1055/a-1307-3997
Ray, S., & Pareek, A. (2023). A systematic review on using virtual assistance‐based education and lifestyle interventions to prevent non-communicable diseases. Journal of Current Science and Technology, 13(1), 118–135. https://doi.org/10.14456/jcst.2023.11
Thiha, P., & Sawasdipong, J. (2025). Efficacy and safety of sonic hedgehog inhibitors and PD-1 inhibitors in locally advanced basal cell carcinoma management: A systematic review and meta-analysis (2013–2023). Journal of Current Science and Technology, 15(2), Article 110. https://doi.org/10.59796/jcst.V15N2.2025.110
Xu, S., Kojima-Yuasa, A., Azuma, H., Huang, X., Norikura, T., Kennedy, D. O., & Matsui-Yuasa, I. (2008). (1′S)-Acetoxychavicol acetate and its enantiomer inhibit tumor cell proliferation via different mechanisms. Chemico-Biological Interactions, 172(3), 216–223. https://doi.org/10.1016/j.cbi.2008.01.002
Xu, X. Y., Zhao, C. N., Cao, S. Y., Tang, G. Y., Gan, R. Y., & Li, H. B. (2020). Effects and mechanisms of tea for the prevention and management of cancers: An updated review. Critical Reviews in Food Science and Nutrition, 60(10), 1693–1705. https://doi.org/10.1080/10408398.2019.1588223
Downloads
Published
How to Cite
License
Copyright (c) 2025 Journal of Current Science and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
